| scholarly article | Q13442814 |
| P2093 | author name string | Guo Cheng | |
| Li Yan | |||
| Li Bin | |||
| Lu Jin | |||
| Yu Qi | |||
| Wan Lili | |||
| Han Yonglong | |||
| Yang Genjin | |||
| Yang Quanjun | |||
| Zhang Junping | |||
| P2860 | cites work | Gene expression profiling predicts clinical outcome of breast cancer | Q27860732 |
| Expression profiling of skeletal muscle following acute and chronic beta2-adrenergic stimulation: implications for hypertrophy, metabolism and circadian rhythm. | Q30157109 | ||
| Chemometrics in metabonomics. | Q30359585 | ||
| Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse. | Q33628125 | ||
| Cachexia in cancer patients | Q33962236 | ||
| Systemic inflammation, cachexia and prognosis in patients with cancer. | Q33986196 | ||
| Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. | Q34002856 | ||
| Metabolic abnormalities in cachexia and anorexia | Q34071896 | ||
| Skeletal muscle loss: cachexia, sarcopenia, and inactivity | Q34099406 | ||
| Formoterol, a highly β2-selective agonist, increases energy expenditure and fat utilisation in men. | Q34277747 | ||
| Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting. | Q34550960 | ||
| Cancer cachexia: mechanisms and clinical implications | Q34631019 | ||
| Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts | Q34714204 | ||
| Amino acids: metabolism, functions, and nutrition | Q34966070 | ||
| Systemic metabolic changes of traumatic critically ill patients revealed by an NMR-based metabonomic approach | Q35008269 | ||
| Chemometric contributions to the evolution of metabonomics: mathematical solutions to characterising and interpreting complex biological NMR spectra | Q35049286 | ||
| Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects | Q35533937 | ||
| Clinical management of anorexia and cachexia in patients with advanced cancer | Q35583122 | ||
| Adverse effects of beta-agonists: are they clinically relevant? | Q35627643 | ||
| Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis | Q35809534 | ||
| The cancer cachexia syndrome: a review of metabolic and clinical manifestations | Q36278394 | ||
| The potential and the pitfalls of beta-adrenoceptor agonists for the management of skeletal muscle wasting | Q37286415 | ||
| Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies | Q37781827 | ||
| Cancer cachexia is regulated by selective targeting of skeletal muscle gene products | Q40529830 | ||
| Cancer cachexia: metabolic alterations and clinical manifestations | Q41371920 | ||
| Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice | Q45735540 | ||
| Metabolic control of the expression of mitochondrial D-beta-hydroxybutyrate dehydrogenase, a ketone body converting enzyme | Q49051873 | ||
| Muscle atrophy in experimental cancer cachexia: is the IGF-1 signaling pathway involved? | Q54448314 | ||
| Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD | Q58316980 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 3015-3025 | |
| P577 | publication date | 2013-09-19 | |
| P1433 | published in | Molecular BioSystems | Q3319467 |
| P1476 | title | Serum metabolic profiles reveal the effect of formoterol on cachexia in tumor-bearing mice | |
| P478 | volume | 9 |
| Q26744140 | Cardiac cachexia: hic et nunc |
| Q48672510 | Distinct Metabolic Profile of Inhaled Budesonide and Salbutamol in Asthmatic Children during Acute Exacerbation |
| Q40315420 | Effect of beta-adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: results from the COPERNICUS trial |
| Q92981949 | Matrine improves skeletal muscle atrophy by inhibiting E3 ubiquitin ligases and activating the Akt/mTOR/FoxO3α signaling pathway in C2C12 myotubes and mice |
| Q39001205 | Muscle wasting in ageing and chronic illness. |
| Q36245459 | Protective Effects of Dexrazoxane against Doxorubicin-Induced Cardiotoxicity: A Metabolomic Study. |
| Q47605033 | Serum and urine metabolomics study reveals a distinct diagnostic model for cancer cachexia |
Search more.